J&J Loses Dutch Stent Trial Against Boston Scientific
Johnson & Johnson will have to stop selling certain drug-coated stents in the Netherlands after rival medical device maker Boston Scientific prevailed in the latest chapter of the companies' extensive litigation....To view the full article, register now.
Already a subscriber? Click here to view full article